BioCentury
ARTICLE | Financial News

Rexahn completes direct public offering

October 21, 2013 7:00 AM UTC

Rexahn Pharmaceuticals Inc. (NYSE-M:RNN), Rockville, Md. Business: Cancer, Neurology, Genitourinary Date completed: 10/11/13 Type: Direct public offering Raised: $5.3 million Units: 10.2 million Price...